Iodozyme-HP (5 mg of metallic iodine and 7.5 mg of potassium iodide per scored tablet) produced by Biotics Research is now available from D.S.D. International, Ltd. This is the combination (5 mg metallic iodine and 7.5 mg potassium iodide) that is recommended by Dr. Abraham and Dr. Brownstein in their written literature. The product is available in 120 tablet glass bottles with a suggested retail cost of $33.50 (professional cost – $16.75) and D.S.D. International, Ltd. DOES NOT require the purchaser to purchase 12 bottles at a time.

CLICK HERE FOR MORE INFORMATION

Why use Iodine/Iodide mixture in your practice?

Regarding the use of iodine/iodide, the following may be useful for you:

IODINE ALTERS GENE EXPRESSION IN THE MCF7 BREAT CANCER CELL LINE: EVIDENCE FOR AN ANTI-ESTROGEN EFFECT OF IODINE, Stoddard and associates, International Journal of Medical Sciences, 2008, #5. The protective effects of iodine/iodide on breast cancer have been postulated from epidemiologic evidence and described in animal models. The molecular mechanisms responsible have not been identified, but laboratory evidence suggests that iodine/iodide may inhibit cancer promotion through the modulation of the estrogen pathway. To elucidate the role of iodine in breast cancer, the effect of iodine/iodide on gene expression was analyzed in the estrogen responsive MCF-7 breast cancer line. Micro-assay identified 29 genes that were up-regulated and 14 genes that were down regulated in response to the iodine/iodine treatment. The altered genes included several involved in hormone metabolism as well as genes involved in the regulation of cell cycle progression, growth and differentiation. This report confirmed the array date demonstrating that iodine/iodide treatment increased the mRNA levels of the estrogen responsive genes TFF1 and WISP2. This report represents the first gene array profiling of the response of a breast cancer line to iodine/iodine treatment. In addition to elucidating our understanding of the effects of iodine/iodide on breast cancer, this work suggests that iodine/iodide may be useful as an adjunctive therapy in the pharmacologic manipulation of the pathway in women with breast cancer.